REMS No Longer Necessary for Rosiglitazone-Containing Diabetes Drugs (FREE)
By Kristin J. Kelley
Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM
The Risk Evaluation and Mitigation Strategy (REMS) for rosiglitazone-containing …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news